Guangdong Taienkang Pharmaceutical Co., Ltd. (SHE:301263)

SHE:301263 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 25, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	15,280	6,348	6,948	7,683	-	-
Market Cap Growth	46.80%	-8.63%	-9.56%	-	-	-
Enterprise Value	15,003	6,066	6,271	6,685	-	-
Last Close Price	36.08	14.88	15.88	17.24	-	-
PE Ratio	162.83	58.66	43.37	44.00	-	-
Forward PE	-	25.85	22.52	-	-	-
PS Ratio	21.32	8.81	9.13	9.81	-	-
PB Ratio	8.27	3.50	3.80	4.14	-	-
P/TBV Ratio	10.91	4.56	4.86	4.36	-	-
P/FCF Ratio	-	305.50	-	130.35	-	-
P/OCF Ratio	182.99	71.07	74.29	51.63	-	-
EV/Sales Ratio	20.94	8.41	8.24	8.53	-	-
EV/EBITDA Ratio	155.85	37.34	28.37	29.48	-	-
EV/EBIT Ratio	158.47	55.12	34.14	34.32	-	-
EV/FCF Ratio	-2656.52	291.91	-	113.43	-	-
Debt / Equity Ratio	0.17	0.13	0.10	0.01	0.15	0.21
Debt / EBITDA Ratio	3.34	1.48	0.79	0.10	0.70	0.59
Debt / FCF Ratio	-	11.68	-	0.39	1.45	3.90
Asset Turnover	0.31	0.32	0.36	0.53	0.74	0.94
Inventory Turnover	2.80	3.33	3.64	4.18	3.70	3.33
Quick Ratio	2.39	2.68	4.21	9.15	2.23	1.64
Current Ratio	2.76	3.05	4.69	9.81	2.66	2.20
Return on Equity (ROE)	4.59%	5.32%	8.33%	13.62%	18.47%	28.25%
Return on Assets (ROA)	2.53%	3.03%	5.38%	8.17%	8.98%	15.85%
Return on Capital (ROIC)	2.78%	3.38%	5.91%	9.03%	10.38%	18.59%
Return on Capital Employed (ROCE)	4.80%	5.70%	9.30%	10.30%	17.30%	31.00%
Earnings Yield	0.62%	1.70%	2.31%	2.27%	-	-
FCF Yield	-0.04%	0.33%	-1.53%	0.77%	-	-
Dividend Yield	0.55%	1.34%	1.89%	2.26%	-	-
Payout Ratio	144.11%	124.86%	104.11%	49.14%	3.56%	42.37%
Buyback Yield / Dilution	-2.15%	1.27%	-6.23%	-24.87%	-6.49%	-5.67%
Total Shareholder Return	-1.59%	2.61%	-4.34%	-22.62%	-6.49%	-5.67%

Updated Oct 28, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.